Monazzah Akbar Sarwar
Clinical Assistant Professor, Pharmacy Practice
About Heading link
Teaching and Supervision Heading link
Undergrad Resrch Pharm Pract (PMPR 380), 8/22/2022 – 12/2/2022
Spec Project in Pharm Pract (PMPR 390), 8/22/2022 – 12/2/2022
PHAR 412 -Student pharmacist role in Community Pharmacy, 1/12/2022 – 1/12/2022
PHAR 411 Otic and Ophthalmic Drug Dispensing, 11/16/2021 – 11/16/2021
PMPR 362 – Neuropathy and Retinal Diabetes, 11/10/2021 – 11/10/2021
Undergrad Resrch Pharm Pract (PMPR 380), 1/11/2021 – 4/30/2021
PHAR 411 (411), 11/17/2020 – Present
PMPR 362 (362), 11/11/2020 – Present
Diabetes elective (PMPR 362), 11/13/2019 – 11/13/2019
A Phase I/II Randomized Placebo-Controlled, Double-Blind, Single-Center, Tolerability And Preliminary Efficacy Clinical Trial Of Recombinant Human Deoxyribonuclease (Rhdnase) Eye Drops In Patients With Ocular Graft-Vs.-Host Disease, Genentech Foundation for Biomedical Sciences., 6/3/2019 - 7/10/2020, No Obligated Amount Set; No Anticipated Amount Set
Dr. Lim's study - EEI pharmacy to compound as needed based on patient randomization, Dr. Jennifer Lim Brimonidine study., 4/1/2019 - 5/13/2022, No Obligated Amount Set; No Anticipated Amount Set
borad-spectrum immunomodulatory eye drop to treat patients with severe dry eye (Dr. Sandeep Jain's grant), National Institutes of Health., Date Not Set - Present, No Obligated Amount Set; No Anticipated Amount Set
★ Katz, EA, Sunshine, S, Mun, C, Sarwar, M, Surenkhuu, B, Pradeep, A, Jain, S. (2022). Combinatorial therapy with immunosuppressive, immunomodulatory and tear substitute eyedrops (“Triple Play”) in Recalcitrant Immunological Ocular Surface Diseases: Combinatorial Therapy in Recalcitrant Immunological Ocular Surface Diseases. Ocular Surface, 23, 1-11. doi:10.1016/j.jtos.2021.11.002.
Surenkhuu, Bayasgalan, Mun, Christine, Atassi, Nour, Dhall, Nikhil, Mun, Jessica, Berek, Caitlin, Kim, Christian, Sarwar, Monazzah Akbar, Pradeep, Anubhav, Jain, Sandeep. (2021). Recombinant Deoxyribonuclease I (DNase) Eye Drops for Ocular Graft vs Hosts Disease (oGVHD): Results of a Randomized Clinical Trial. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 62, (8).
★ Kwon, J, Surenkhuu, B, Raju, I, Atassi, N, Mun, J, Chen, YF, Sarwar, MA, Rosenblatt, M, Pradeep, A, An, S, Dhall, N, Mun, C, Jain, S. (2020). Pathological consequences of anti-citrullinated protein antibodies in tear fluid and therapeutic potential of pooled human immune globulin-eye drops in dry eye disease. Ocular Surface, 18, (1), 80-97. doi:10.1016/j.jtos.2019.10.004.
Ambulatory Care Network, 4/7/2022 - 4/7/2023
COVID vaccine testing and challenge desensitizations, 2/1/2021 - 4/30/2021
Formulate leucovorin eye drops, 12/28/2020 - 12/28/2020
Transition to EPIC, 9/12/2020 - 4/30/2021
Working through work stoppage in Sept overlapping with Go-live with EPIC, 9/11/2020 - 9/25/2020
Ophthalmology resident and fellow orientation, 7/16/2020 - Present
Assisting University of Maryland set-up GvHD clinic, 7/1/2020 - 12/30/2020
Amb Care Policy and Procedure Comm, 6/1/2020 - Present
Courier for sterile compounds, 4/1/2020 - 4/30/2021
2022, Best Encore poster presentation, Illinois Council of Health-System Pharmacists (ICHP)
Akbar Sarwar, Monazzah. (2022 January 13). Testing for COVID-19 vaccine allergies. Vizient Pharmacy Network Meeting. Virtual.